The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks
Centers for Disease Control and Prevention Office of Health Care Partnerships. He has served on several National Academies committees and is a member of the Roundtable on Evidence-Based Medicine. Dr. Platt received his MD from Harvard Medical School.
Kimberly M. Thompson is associate professor of risk analysis and decision science at the Harvard School of Public Health. Her research is related to developing and applying quantitative methods for risk assessment and risk management and the public-policy implications of including uncertainty and variability in risk characterization. She has served on several National Academies committees, including the Committee for the Study of a Motor Vehicle Rollover Rating System and the Subcommittee to Update the 1999 Arsenic Report. She is a member of the Board on Environmental Studies and Toxicology. Dr. Thompson received her ScD in environmental health from the Harvard School of Public Health.